83 related articles for article (PubMed ID: 1704186)
1. Binding of tumor necrosis factor alpha to activated forms of human plasma alpha 2 macroglobulin.
Wollenberg GK; LaMarre J; Rosendal S; Gonias SL; Hayes MA
Am J Pathol; 1991 Feb; 138(2):265-72. PubMed ID: 1704186
[TBL] [Abstract][Full Text] [Related]
2. LincRNA00612 inhibits apoptosis and inflammation in LPS-induced BEAS-2B cells via enhancing interaction between p-STAT3 and A2M promoter.
Xiao X; Cai W; Ding Z; Mao Z; Shi Y; Zhang Q
PeerJ; 2023; 11():e14986. PubMed ID: 36883061
[TBL] [Abstract][Full Text] [Related]
3. Proteomic Analysis of Retinal Tissue in an S100B Autoimmune Glaucoma Model.
Reinehr S; Guntermann A; Theile J; Benning L; Grotegut P; Kuehn S; Serschnitzki B; Dick HB; Marcus K; Joachim SC; May C
Biology (Basel); 2021 Dec; 11(1):. PubMed ID: 35053014
[TBL] [Abstract][Full Text] [Related]
4. Alpha-2-Macroglobulin in Inflammation, Immunity and Infections.
Vandooren J; Itoh Y
Front Immunol; 2021; 12():803244. PubMed ID: 34970276
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor receptor-1 is selectively sequestered into Schwann cell extracellular vesicles where it functions as a TNFα decoy.
Sadri M; Hirosawa N; Le J; Romero H; Martellucci S; Kwon HJ; Pizzo D; Ohtori S; Gonias SL; Campana WM
Glia; 2022 Feb; 70(2):256-272. PubMed ID: 34559433
[TBL] [Abstract][Full Text] [Related]
6. Regulation of ADAMTS Proteases.
Rose KWJ; Taye N; Karoulias SZ; Hubmacher D
Front Mol Biosci; 2021; 8():701959. PubMed ID: 34268335
[TBL] [Abstract][Full Text] [Related]
7. Alpha-2-Macroglobulin, a Hypochlorite-Regulated Chaperone and Immune System Modulator.
Cater JH; Wilson MR; Wyatt AR
Oxid Med Cell Longev; 2019; 2019():5410657. PubMed ID: 31428227
[TBL] [Abstract][Full Text] [Related]
8. Early supplemental α2-macroglobulin attenuates cartilage and bone damage by inhibiting inflammation in collagen II-induced arthritis model.
Li S; Xiang C; Wei X; Sun X; Li R; Li P; Sun J; Wei D; Chen Y; Zhang Y; Wei L
Int J Rheum Dis; 2019 Apr; 22(4):654-665. PubMed ID: 30609267
[TBL] [Abstract][Full Text] [Related]
9. Targeted designed variants of alpha-2-macroglobulin (A2M) attenuate cartilage degeneration in a rat model of osteoarthritis induced by anterior cruciate ligament transection.
Zhang Y; Wei X; Browning S; Scuderi G; Hanna LS; Wei L
Arthritis Res Ther; 2017 Jul; 19(1):175. PubMed ID: 28743292
[TBL] [Abstract][Full Text] [Related]
10. The Role of Clinical Proteomics, Lipidomics, and Genomics in the Diagnosis of Alzheimer's Disease.
Martins IJ
Proteomes; 2016 Mar; 4(2):. PubMed ID: 28248224
[TBL] [Abstract][Full Text] [Related]
11. Identification of α2-macroglobulin as a master inhibitor of cartilage-degrading factors that attenuates the progression of posttraumatic osteoarthritis.
Wang S; Wei X; Zhou J; Zhang J; Li K; Chen Q; Terek R; Fleming BC; Goldring MB; Ehrlich MG; Zhang G; Wei L
Arthritis Rheumatol; 2014 Jul; 66(7):1843-53. PubMed ID: 24578232
[TBL] [Abstract][Full Text] [Related]
12. Hepcidin bound to α2-macroglobulin reduces ferroportin-1 expression and enhances its activity at reducing serum iron levels.
Huang ML; Austin CJD; Sari MA; Suryo Rahmanto Y; Ponka P; Vyoral D; Richardson DR
J Biol Chem; 2013 Aug; 288(35):25450-25465. PubMed ID: 23846698
[TBL] [Abstract][Full Text] [Related]
13. Gene regulation networks related to neural differentiation of hESC.
Zhong JF; Song Y; Du J; Gamache C; Burke KA; Lund BT; Weiner LP
Gene Expr; 2007; 14(1):23-34. PubMed ID: 17933216
[TBL] [Abstract][Full Text] [Related]
14. Interaction of transforming growth factor-beta-1 with alpha-2-macroglobulin from normal and inflamed equine joints.
Coté N; Trout DR; Hayes MA
Can J Vet Res; 1998 Oct; 62(4):279-86. PubMed ID: 9798094
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of intracellular proteolytic processing of soluble proproteins by an engineered alpha 2-macroglobulin containing a furin recognition sequence in the bait region.
Van Rompaey L; Ayoubi T; Van De Ven W; Marynen P
Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):507-14. PubMed ID: 9291125
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of plasma alpha-2-macroglobulin and interactions with tumour necrosis factor-alpha in horses with endotoxemic signs.
Coté N; Trout DR; Hayes AM
Can J Vet Res; 1996 Apr; 60(2):150-7. PubMed ID: 8785722
[TBL] [Abstract][Full Text] [Related]
17. Malaria: a tumour necrosis factor inhibitor from parasitized erythrocytes.
Sheikh NA; Caro HN; Taverne J; Playfair JH; Rademacher TW
Immunology; 1996 Mar; 87(3):461-6. PubMed ID: 8778034
[TBL] [Abstract][Full Text] [Related]
18. Differences in the binding of transforming growth factor beta 1 to the acute-phase reactant and constitutively synthesized alpha-macroglobulins of rat.
Webb DJ; Crookston KP; Figler NL; Lamarre J; Gonias SL
Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):579-86. PubMed ID: 8526873
[TBL] [Abstract][Full Text] [Related]
19. Removal of pro-inflammatory cytokines with renal replacement therapy: sense or nonsense?
Schetz M; Ferdinande P; Van den Berghe G; Verwaest C; Lauwers P
Intensive Care Med; 1995 Feb; 21(2):169-76. PubMed ID: 7775699
[No Abstract] [Full Text] [Related]
20. Binding of platelet-derived growth factor-BB and transforming growth factor-beta 1 to alpha 2-macroglobulin in vitro and in vivo: comparison of receptor-recognized and non-recognized alpha 2-macroglobulin conformations.
Crookston KP; Webb DJ; Lamarre J; Gonias SL
Biochem J; 1993 Jul; 293 ( Pt 2)(Pt 2):443-50. PubMed ID: 7688216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
